W. Brooks Gentry
Gründer bei InterveXion Therapeutics LLC
Aktive Positionen von W. Brooks Gentry
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
InterveXion Therapeutics LLC
 InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Technik-/Wissenschafts-/F&E-Leiter | 17.09.2009 | - |
| Gründer | 17.09.2009 | - | |
| The University of Arkansas | Corporate Officer/Principal | 17.09.2009 | - |
Karriereverlauf von W. Brooks Gentry
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
InterveXion Therapeutics LLC
InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Health Technology |
- Börse
- Insiders
- W. Brooks Gentry
- Erfahrung
